Author:
Bootorabi Fatemeh,Jänis Janne,Valjakka Jarkko,Isoniemi Sari,Vainiotalo Pirjo,Vullo Daniela,Supuran Claudiu T,Waheed Abdul,Sly William S,Niemelä Onni,Parkkila Seppo
Abstract
Abstract
Background
Acetaldehyde, the first metabolite of ethanol, can generate covalent modifications of proteins and cellular constituents. However, functional consequences of such modification remain poorly defined. In the present study, we examined acetaldehyde reaction with human carbonic anhydrase (CA) isozyme II, which has several features that make it a suitable target protein: It is widely expressed, its enzymatic activity can be monitored, its structural and catalytic properties are known, and it contains 24 lysine residues, which are accessible sites for aldehyde reaction.
Results
Acetaldehyde treatment in the absence and presence of a reducing agent (NaBH3(CN)) caused shifts in the pI values of CA II. SDS-PAGE indicated a shift toward a slightly higher molecular mass. High-resolution mass spectra of CA II, measured with and without NaBH3(CN), indicated the presence of an unmodified protein, as expected. Mass spectra of CA II treated with acetaldehyde revealed a modified protein form (+26 Da), consistent with a "Schiff base" formation between acetaldehyde and one of the primary NH2 groups (e.g., in lysine side chain) in the protein structure. This reaction was highly specific, given the relative abundance of over 90% of the modified protein. In reducing conditions, each CA II molecule had reacted with 9–19 (14 on average) acetaldehyde molecules (+28 Da), consistent with further reduction of the "Schiff bases" to substituted amines (N-ethyllysine residues). The acetaldehyde-modified protein showed decreased CA enzymatic activity.
Conclusion
The acetaldehyde-derived modifications in CA II molecule may have physiological consequences in alcoholic patients.
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Biochemistry
Reference66 articles.
1. Lieber CS: Medical disorders of alcoholism. N Engl J Med. 1995, 333 (16): 1058-1065.
2. Niemela O, Parkkila S, Yla-Herttuala S, Halsted C, Witztum JL, Lanca A, Israel Y: Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest. 1994, 70 (4): 537-546.
3. Freeman TL, Tuma DJ, Thiele GM, Klassen LW, Worrall S, Niemela O, Parkkila S, Emery PW, Preedy VR: Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res. 2005, 29 (7): 1310-1316.
4. Tuma DJ, Klassen LW: Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology. 1992, 103 (6): 1969-1973.
5. Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CM: Acetaldehyde adducts with hemoglobin. J Clin Invest. 1981, 67 (2): 361-369.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献